Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.72 USD | -3.55% |
|
-13.92% | +63.86% |
05-30 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
05-07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
Sales 2024 * | 77.83M 107M | Sales 2025 * | 90.51M 124M | Capitalization | 262M 359M |
---|---|---|---|---|---|
Net income 2024 * | -179M -245M | Net income 2025 * | -172M -236M | EV / Sales 2024 * | 1.69 x |
Net cash position 2024 * | 130M 179M | Net cash position 2025 * | 88.83M 122M | EV / Sales 2025 * | 1.91 x |
P/E ratio 2024 * |
-1.44
x | P/E ratio 2025 * |
-1.72
x | Employees | 274 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.08% |
Latest transcript on ADC Therapeutics SA
1 day | -3.55% | ||
1 week | -13.92% | ||
Current month | -20.70% | ||
1 month | -33.66% | ||
3 months | -41.76% | ||
6 months | +101.48% | ||
Current year | +63.86% |
![Extreme 2.7](/images/extremecours_fleche.png)
![Extreme 2.7](/images/extremecours_fleche.png)
![Extreme 1.4501](/images/extremecours_fleche.png)
![Extreme 0.3599](/images/extremecours_fleche.png)
![Extreme 0.3599](/images/extremecours_fleche.png)
![Extreme 0.3599](/images/extremecours_fleche.png)
![Extreme 0.3599](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 51 | 22-05-08 |
Jose Carmona
DFI | Director of Finance/CFO | 51 | 22-12-18 |
Mohamed Zaki
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-01-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Hug
BRD | Director/Board Member | 65 | 19-05-31 |
Ron Squarer
CHM | Chairman | 57 | 20-03-31 |
Jean Bizzari
BRD | Director/Board Member | 69 | 22-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-18 | 2.72 | -3.55% | 407,849 |
24-06-17 | 2.82 | -14.55% | 831,041 |
24-06-14 | 3.3 | +4.43% | 421,387 |
24-06-13 | 3.16 | 0.00% | 403,195 |
24-06-12 | 3.16 | +0.64% | 2,058,218 |
Delayed Quote Nyse, June 18, 2024 at 04:00 pm
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.86% | 262M | |
+14.84% | 121B | |
+18.31% | 112B | |
+4.28% | 22.57B | |
-18.26% | 20.82B | |
-17.05% | 16.19B | |
-42.36% | 16.17B | |
-14.23% | 16.3B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- ADCT Stock